These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7572471)

  • 1. Marek's disease and new approaches to its control.
    Zelník V
    Acta Virol; 1995 Feb; 39(1):53-63. PubMed ID: 7572471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marek's disease--the disease and its prevention by vaccination.
    Biggs PM
    Br J Cancer Suppl; 1975 Mar; 2():152-5. PubMed ID: 170953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a cell line system susceptible to infection with vaccine strains of MDV.
    Abujoub AA; Williams DL; Reilly JD
    Acta Virol; 1999; 43(2-3):186-91. PubMed ID: 10696443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.
    Nazerian K; Witter RL; Lee LF; Yanagida N
    Avian Dis; 1996; 40(2):368-76. PubMed ID: 8790888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity.
    Witter RL; Bacon LD; Calvert JG
    Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marek's disease in turkeys: lack of protection by vaccination.
    Elmubarak AK; Sharma JM; Witter RL; Sanger VL
    Am J Vet Res; 1982 Apr; 43(4):740-2. PubMed ID: 6280536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of Marek's disease: a review.
    Purchase HG
    Cancer Res; 1976 Feb; 36(2 pt 2):696-700. PubMed ID: 766959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marek's disease: a model for protection against herpesvirus-induced tumours.
    Schat KA
    Cancer Surv; 1987; 6(1):1-37. PubMed ID: 2825984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease.
    Calnek BW; Schat KA; Peckham MC; Fabricant J
    Avian Dis; 1983; 27(3):844-9. PubMed ID: 6314982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marek's disease vaccines.
    Calnek BW
    Dev Biol Stand; 1982; 52():401-5. PubMed ID: 6299850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marek's disease tumors in chickens vaccinated with turkey herpesvirus vaccine.
    Eidson CS
    Dev Biol Stand; 1982; 52():437-46. PubMed ID: 7166202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
    Baigent SJ; Smith LP; Nair VK; Currie RJ
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
    Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
    Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of Marek's disease -- a paradigm for incessant race between the pathogen and the host.
    Nair V
    Vet J; 2005 Sep; 170(2):175-83. PubMed ID: 16129338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marek's disease: an update on oncogenic mechanisms and control.
    Venugopal K
    Res Vet Sci; 2000 Aug; 69(1):17-23. PubMed ID: 10924389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Marek's disease vaccines: could they be driving the virus to increasing virulence?
    Davison F; Nair V
    Expert Rev Vaccines; 2005 Feb; 4(1):77-88. PubMed ID: 15757475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New serotype 2 and attenuated serotype 1 Marek's disease vaccine viruses: comparative efficacy.
    Witter RL
    Avian Dis; 1987; 31(4):752-65. PubMed ID: 2831867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of CVI988/Rispens and R2/23, two prototype vaccine strains of serotype 1 Marek's disease virus.
    Witter RL; Lee LF; Fadly AM
    Avian Dis; 1995; 39(2):269-84. PubMed ID: 7677647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of Marek's disease in Japanese quails vaccinated with herpesvirus of turkeys.
    Kobayashi S; Kobayashi K; Mikami T
    Avian Dis; 1986; 30(4):816-9. PubMed ID: 3814019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
    Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.